Breaking News
Get 55% Off 0
Get Premium Data for Cyber Monday: Up to 55% Off InvestingPro
CLAIM SALE
Close

Clinica Baviera (CBAV)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
33.000 -0.800    -2.37%
06/12 - Closed. Currency in EUR
Type:  Equity
Market:  Spain
ISIN:  ES0119037010 
  • Volume: 2,179
  • Bid/Ask: 32.500 / 33.800
  • Day's Range: 32.900 - 34.100
Clinica Baviera 33.000 -0.800 -2.37%

BME:CBAV Financials

 
Explore the BME:CBAV financials. Find the Clinica Baviera financial statements for a comprehensive overview of the company’s financial health. This summary highlights critical numbers from key financial reports, including the Clinica Baviera annual report, the income statement, balance sheet, and cash flow statement. Gain deeper insights with financial ratios that assess the company's performance and stability. Users can customize their view by selecting data from four periods of either annual or quarterly information, making it easy to track the financial performance of Clinica Baviera over time.

Clínica Baviera, S.A. reported earnings results for the nine months ended September 30, 2024. For the nine months, the company reported sales was EUR 189 million compared to EUR 163.59 million a year ago. Net income was EUR 28.02 million compared to EUR 26.92 million a year ago.

AnnualQuarterly  
Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

CBAV Income Statement

Gross margin TTM 45.93%
Operating margin TTM 20.33%
Net Profit margin TTM 14.68%
Return on Investment TTM 26.89%
 Total Revenue  Net Income
Period Ending: Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023
Total Revenue 56.03 66.48 66.48 63.47
Gross Profit -14.58 33.88 33.88 62.79
Operating Income 5.81 16.15 16.15 13.22
Net Income 4.59 11.71 11.71 9.05

CBAV Balance Sheet

Quick Ratio MRQ 0.8
Current Ratio MRQ 0.8
LT Debt to Equity MRQ 9.61%
Total Debt to Equity MRQ 73.41%
 Total Assets  Total Liabilities
Period Ending: Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023
Total Assets 202.74 203.01 203.01 178.64
Total Liabilities 117.63 122.06 122.06 86.37
Total Equity 85.1 80.95 80.95 92.28

CBAV Cash Flow Statement

Cash Flow/Share TTM 3.87
Revenue/Share TTM 15.49
Operating Cash Flow  17.10%
 Cash  Net Change in Cash
Period Ending: Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities 8.84 19.15 19.15 15.89
Cash From Investing Activities -3.76 -12.07 -12.07 -30.38
Cash From Financing Activities -21.19 -7.72 -7.72 -2.58
Net Change in Cash -16.21 -0.638 -0.638 -17.07
* In Millions of EUR (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

CBAV Comments

Write your thoughts about Clinica Baviera
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Carlos Andres
Carlos Andres Feb 09, 2021 5:40AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Con todas las operaciones bloqueadas en la Sanidad pública, es el momento de la sanidad privada, en cirugía refractiva y en todo. Fuga de pacientes públicos a la privada. Ya se verá en los resultados
Carlos Andres
Carlos Andres Dec 15, 2020 9:35AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Sube... Toca pensar si seguir o salir. Yo esperaré al menos hasta 13 eur
Leo Lilja
Leo Lilja Dec 15, 2020 9:35AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Si compraste a buen precio, creo que es una inversion para no tocar, tienes tantas dinamicas de poblacion ayudando al crecimiento de la empresa...
Carlos Andres
Carlos Andres Dec 07, 2020 7:22AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Still time to buy
Leo Lilja
Leo Lilja Dec 07, 2020 7:22AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buenas Carlos, yo he estado comprando muchas acciones durante los ultimos 6 meses, creo que esta es una compañia de calidad que puede crecer durante muchos años, tu que opinas?
Carlos Andres
Carlos Andres Dec 07, 2020 7:22AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Su informe financiero parece muy bueno. Además la sanidad pública está parada para operaciones médicas no urgentes, así que todo empuja hacia arriba.
Carlos Andres
Carlos Andres Dec 07, 2020 7:22AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Leo Lilja  Su informe financiero parece muy bueno. Además la sanidad pública está parada para operaciones médicas no urgentes, así que todo empuja hacia arriba.
Carlos Andres
Carlos Andres Nov 16, 2020 8:04AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
very strong now. time to buy
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email